# MARK1

## Relevance tier by entity

|Entity|Tier|Description                              |
|:------:|:----:|-----------------------------------------|
|DLBCL |2   |relevance in DLBCL not firmly established|

## Mutation incidence in large patient cohorts (GAMBL reanalysis)

|Entity|source        |frequency (%)|
|:------:|:--------------:|:-------------:|
|DLBCL |GAMBL genomes |0.57         |
|DLBCL |Schmitz cohort|1.91         |
|DLBCL |Reddy cohort  |1.30         |
|DLBCL |Chapuy cohort |0.43         |

## Mutation pattern and selective pressure estimates

|Entity|aSHM|Significant selection|dN/dS (missense)|dN/dS (nonsense)|
|:------:|:----:|:---------------------:|:----------------:|:----------------:|
|BL    |No  |No                   |0.923           |0               |
|DLBCL |No  |No                   |0.000           |0               |
|FL    |No  |No                   |2.768           |0               |


> [!NOTE]
> First described in DLBCL in 2017 by [Reddy A](https://pubmed.ncbi.nlm.nih.gov/28985567)


View coding variants in ProteinPaint [hg19](https://www.bcgsc.ca/downloads/morinlab/GAMBL/test/genes/MARK1_protein.html)  or [hg38](https://www.bcgsc.ca/downloads/morinlab/GAMBL/test/genes/MARK1_protein_hg38.html)

![image](images/proteinpaint/MARK1_NM_018650.svg)

View all variants in GenomePaint [hg19](https://www.bcgsc.ca/downloads/morinlab/GAMBL/test/genes/MARK1.html)  or [hg38](https://www.bcgsc.ca/downloads/morinlab/GAMBL/test/genes/MARK1_hg38.html)

![image](images/proteinpaint/MARK1.svg)
